This department is offering grants to support research on the impact of chemical modifications on intact and defective HIV RNA and identify therapeutic targets for future HIV cure strategies. The goal is to enhance understanding of post-transcriptional regulation of HIV RNA. Deadline for applications is August 4, 2021.
Opportunity ID: 332491
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-21-012 |
| Funding Opportunity Title: | Understanding Post-Transcriptional Regulation of Intact and Defective HIV RNA (R61/R33 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 31, 2021 |
| Last Updated Date: | Mar 31, 2021 |
| Original Closing Date for Applications: | Aug 04, 2021 |
| Current Closing Date for Applications: | Aug 04, 2021 |
| Archive Date: | Sep 09, 2021 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Special district governments Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts City or township governments For profit organizations other than small businesses State governments Native American tribal governments (Federally recognized) Private institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages exploratory and developmental bi-phasic research applications to support the understanding of how HIV RNA chemical modifications impact expression of intact and defective HIV and the identification of potential therapeutic targets for future HIV cure strategies. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-21-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00266291 | Jul 05, 2021 | Aug 04, 2021 | View |
Package 1
Mandatory forms
332491 RR_SF424_2_0-2.0.pdf
332491 PHS398_CoverPageSupplement_5_0-5.0.pdf
332491 RR_OtherProjectInfo_1_4-1.4.pdf
332491 PerformanceSite_2_0-2.0.pdf
332491 RR_KeyPersonExpanded_2_0-2.0.pdf
332491 RR_Budget_1_4-1.4.pdf
332491 PHS398_ResearchPlan_4_0-4.0.pdf
332491 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
332491 RR_SubawardBudget30_1_4-1.4.pdf
332491 PHS_AssignmentRequestForm_3_0-3.0.pdf